Last updated on June 2019

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients


Brief description of study

The overall purpose of this study is to determine the efficacy of fevipiprant (dose 1 and dose 2 once daily), compared with placebo, as add-on to standard-of-care asthma therapy, in terms of avoidance of coricosteroid use over 52 weeks.

Clinical Study Identifier: NCT03629249

Find a site near you

Start Over

Novartis Investigative Site

Newport Beach, CA United States
  Connect »

Novartis Investigative Site

Westminster, CA United States
  Connect »

Novartis Investigative Site

Winter Park, FL United States
  Connect »

Novartis Investigative Site

Marietta, GA United States
  Connect »

Novartis Investigative Site

Waldorf, MD United States
  Connect »

Novartis Investigative Site

McKinney, TX United States
  Connect »

Novartis Investigative Site

San Miguel de Tucuman, Argentina
  Connect »

Novartis Investigative Site

Jindrichuv Hradec, Czechia
  Connect »

Novartis Investigative Site

Montpellier cedex 5, France
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Spisska Nova Ves, Slovakia
  Connect »

Novartis Investigative Site

Santiago de Compostela, Spain
  Connect »

Novartis Investigative Site

Portsmouth, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.